"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.
The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.
“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.
“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.
James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.
“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.
“There are a lot of NIH officials who resent t***sparency,” he added."
“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”MY COMMENT: YA THINK!!!https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge
AuntiE
Loc: 45th Least Free State
ACP45 wrote:
"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.
The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.
“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.
“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.
James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.
“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.
“There are a lot of NIH officials who resent t***sparency,” he added."
“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”MY COMMENT: YA THINK!!!https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge"The U.S. National Institutes of Health (NIH)... (
show quote)
If one were to have access to NIH, HHS, and CDC upper level personnel’ investment portfolios, seeing their rate of return in their pharmaceutical investments would provide some information.
AuntiE wrote:
If one were to have access to NIH, HHS, and CDC upper level personnel’ investment portfolios, seeing their rate of return in their pharmaceutical investments would provide some information.
Indeed! Follow the money!
ACP45 wrote:
"The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a C****-** v*****e that has earned it at least $400 million.
The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.
“The NIH withholds the entirety of the records as they are protected from release,” Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.
“Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,” she added.
James Love, director of the nonprofit Knowledge Ecology International, said the information should be made public.
“The NIH put out several press statements about the royalty dispute with M*****a, and they should not now claim it is some secret confidential information. And when hundreds of millions of dollars are at stake, the public interest in t***sparency is large too,” Mr. Love told The Epoch Times in an email.
“There are a lot of NIH officials who resent t***sparency,” he added."
“Neither the government nor any government employee should have any financial interest in a product for which the government has any involvement in licensing or promoting,“ Aaron Siri, managing partner of Siri & Glimstad LLP, told The Epoch Times in an email. ”It creates a dangerous conflict of interest.”MY COMMENT: YA THINK!!!https://www.theepochtimes.com/us/nih-refuses-to-release-details-of-c****-**-v*****e-royalty-agreement-5629631?utm_source=partner&utm_campaign=ZeroHedge&src_src=partner&src_cmp=ZeroHedge"The U.S. National Institutes of Health (NIH)... (
show quote)
Way back at the beginning, when it came out that the pharm companies couldn't be sued, I knew they were no good
If you want to reply, then
register here. Registration is free and your account is created instantly, so you can post right away.